Johanna Weiss Selected Research

Prostatic Neoplasms (Prostate Cancer)

12/2017	Impact of enzalutamide and its main metabolite N-desmethyl enzalutamide on pharmacokinetically important drug metabolizing enzymes and drug transporters.
10/2011	Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johanna Weiss Research Topics

Disease

25	Breast Neoplasms (Breast Cancer) 02/2022 - 09/2005
19	Neoplasms (Cancer) 03/2024 - 04/2010
9	Infections 06/2024 - 05/2007
7	Squamous Cell Carcinoma of Head and Neck 01/2018 - 07/2011
5	Multiple Myeloma 01/2019 - 06/2014
4	COVID-19 04/2021 - 06/2020
4	Pulmonary Arterial Hypertension 02/2015 - 01/2013
3	Leukemia 05/2023 - 10/2006
3	Drug-Related Side Effects and Adverse Reactions 01/2014 - 03/2004
2	Chronic Hepatitis B 01/2023 - 01/2018
2	Inflammation (Inflammations) 01/2021 - 03/2003
2	Oropharyngeal Neoplasms 10/2019 - 01/2018
2	Body Weight (Weight, Body) 04/2019 - 04/2014
2	Dyslipidemias (Dyslipidemia) 01/2019 - 01/2004
2	Prostatic Neoplasms (Prostate Cancer) 12/2017 - 10/2011
2	Morbid Obesity 06/2017 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 11/2015 - 12/2009
2	Hypertension (High Blood Pressure) 07/2010 - 03/2003
1	Seizures (Absence Seizure) 06/2024
1	Cerebral Toxoplasmosis 06/2024
1	Cardiotoxicity 01/2024
1	Rheumatic Diseases (Rheumatism) 12/2023
1	Chronic Disease (Chronic Diseases) 12/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2023
1	Cushing Syndrome 02/2023
1	Hepatitis B 01/2023
1	Ependymoma 09/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 02/2022 - 09/2005
22	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2021 - 09/2005
10	Peptides (Polypeptides)IBA 02/2022 - 01/2012
8	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019 - 09/2005
7	EnzymesIBA 01/2024 - 01/2012
7	AnionsIBA 02/2022 - 05/2013
5	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2023 - 01/2004
5	Cytochrome P-450 CYP3AIBA 02/2022 - 02/2015
5	multidrug resistance-associated protein 1IBA 02/2019 - 09/2005
5	Bortezomib (Velcade)FDA Link 01/2019 - 06/2014
5	Messenger RNA (mRNA)IBA 08/2015 - 11/2010
4	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 07/2011
4	Cytochrome P-450 CYP2C19IBA 02/2022 - 08/2006
4	Pregnane X ReceptorIBA 10/2019 - 05/2013
4	Voriconazole (Vfend)FDA LinkGeneric 04/2019 - 08/2006
4	Bosentan (Tracleer)FDA Link 01/2019 - 06/2011
4	pheophorbide aIBA 11/2015 - 04/2011
4	fluorexon (calcein)IBA 11/2015 - 04/2011
4	Fluorouracil (Carac)FDA LinkGeneric 04/2014 - 12/2009
4	Cytostatic AgentsIBA 04/2012 - 12/2009
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2023 - 06/2020
3	Multidrug Resistance-Associated ProteinsIBA 02/2019 - 09/2005
3	IsoenzymesIBA 11/2015 - 01/2004
3	ambrisentan FDA Link 02/2015 - 06/2011
3	Endothelin A ReceptorIBA 02/2015 - 01/2013
2	Ketoconazole (Nizoral)FDA LinkGeneric 02/2023 - 02/2022
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 02/2022 - 08/2014
2	Organic Anion TransportersIBA 04/2021 - 09/2020
2	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 09/2020 - 08/2015
2	Phytoestrogens (Phytoestrogen)IBA 02/2019 - 01/2016
2	GenisteinIBA 02/2019 - 01/2016
2	Endothelin Receptors (Endothelin Receptor)IBA 01/2019 - 10/2011
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019 - 01/2018
2	Fluorescent Dyes (Fluorescent Probes)IBA 01/2018 - 02/2016
2	Fentanyl (Sublimaze)FDA LinkGeneric 06/2017 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 11/2015
2	obatoclaxIBA 11/2015 - 11/2015
2	Multidrug Resistance-Associated Protein 2IBA 02/2015 - 04/2011
2	Proteasome InhibitorsIBA 02/2015 - 06/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2014 - 07/2011
2	Telmisartan (Micardis)FDA Link 01/2014 - 07/2010
2	LipidsIBA 03/2013 - 10/2007
2	CholesterolIBA 03/2013 - 10/2007
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2012 - 12/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2012 - 01/2003
2	Reverse Transcriptase InhibitorsIBA 03/2011 - 05/2007
2	Adenosine Triphosphate (ATP)IBA 10/2007 - 09/2005
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2024
1	Double-Stranded RNA (RNA, Double Stranded)IBA 03/2024
1	Toll-Like Receptor 3IBA 03/2024
1	RNA (Ribonucleic Acid)IBA 03/2024
1	idarubicinolIBA 01/2024
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2024
1	AnthracyclinesIBA 01/2024
1	Ritonavir (Norvir)FDA Link 12/2023
1	AntigensIBA 05/2023
1	Lenalidomide (CC 5013)FDA Link 05/2023
1	Programmed Cell Death 1 ReceptorIBA 05/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	bulevirtideIBA 01/2023
1	Large Neutral Amino Acid-Transporter 1IBA 03/2022
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 03/2022
1	Dactinomycin (Actinomycin)FDA LinkGeneric 09/2021
1	4-(4-guanidinobenzoyloxy)phenylacetic acidIBA 04/2021
1	Serine Proteases (Serine Protease)IBA 04/2021
1	camostatIBA 04/2021

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2016 - 09/2005
8	Therapeutics 04/2019 - 03/2004
2	Bariatric Surgery 06/2017 - 01/2017
2	TP protocol 04/2014 - 05/2013
1	Hematopoietic Stem Cell Transplantation 06/2024
1	Polypharmacy 12/2023